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Abstract Case Description Discussion
Introduction: Epinephrine and epinephrine related medications have been widely studied
and their side effect profiles have been well documented. Rare reactions can occur due to
administration of EpiPen and it is critical to document and explore the cause of such
reactions. We present a case report on a patient experiencing a unique reaction to EpiPen
administration which we suspect is due to vasospasm.
Case Description: A 38-year-old Caucasian female presented after a bee sting and
subsequent EpiPen self-administration. She had no past medical history except for
anaphylactic reaction to a bee sting in her childhood, and had undergone desensitization with
an allergist. En route to the hospital, she developed: chest pressure, palpitations, facial
droop, dysarthria, and decreased strength. The patient’s vital signs were within normal range.
Blood work was notable for hypokalemia, hyperglycemia and lactic acidosis. CT head with
angiography was unremarkable. Neurology was consulted and her MRI brain showed no
evidence of acute stroke. Within three hours of hospital admission her symptoms had
resolved. The patient was monitored overnight, and subsequently discharged the next day
with no residual deficits.
Discussion: The EpiPen is widely used for immediate relief of impending anaphylaxis. We
believe this patient’s angina and TIA-like symptoms were secondary to non-specific
vasospasm given the alpha-adrenergic mechanism of epinephrine. A literature review
showed limited information on such reactions after EpiPen injection.
Conclusion: It is imperative that physicians are aware of such potential adverse effects in
order to enhance patient care
• A 38-year-old Caucasian female with notable past history for bee-sting related anaphylaxis was stung by
a bee while hiking
• EpiPen® was self-administered into the left thigh and EMS was contacted. She had never previously
administered EpiPen® in the past. Upon EMS arrival the patient received diphenhydramine 50 mg
orally and an albuterol inhaler for wheezing on examination. Examination findings were otherwise
benign.
• En route to the hospital, approximately 10 minutes after medication administration, the patient
developed new left facial droop, pressure-like chest pain and progressive focal motor weakness
• The patients past medical history is significant for history of bee-sting related anaphylaxis at age 10,
requiring hospitalization without need for intubation. Other history includes history of reactive
depression following her brothers suicide.
• Following childhood hospitalization, the patient underwent desensitization therapy with an allergist. She
was prescribed EpiPen however has never previously had to administer it
• Past surgical history is only notable for a cesarean section 2 years prior to hospitalization due to failure
of trial of labor and delivery at home
• The patient does not take any medications, vitamins or supplements. She does not follow with
recommended vaccinations, does not follow with a primary care physician and is vegan. She is a stay-at-
home mother, with no history of alcohol, tobacco or drug use.
• Family history is notable lupus and type 2 diabetes in her mother, and hypertension in her father.
• On hospital arrival, blood pressure 121/77, pulse 101, temperature 37.5°C, respiratory rate 18 with
oxygen saturation at 97% on room air, BMI 24
• On examination, bilateral facial droop was noted, more prominent on the left side. She was unable to
raise her left eyebrow and had developed new dysarthria with inability to verbalize her thoughts.
Additionally she was unable to actively move her extremities
• Initial blood work (See table 1.) was notable for hypokalemia, and hyperglycemia
• EKG showing normal sinus rhythm, chest x-ray and CT head with angiography without acute
abnormalities. Solumedrol and famotidine were administered.
• Over the following three hours of hospitalization, the patient had progressive improvement in her motor
strength and ability to verbalize. Cranial nerves II-XII were all intact except for residual inability to lift
left the left eyebrow.
• Neurology was consulted and the patient was monitored overnight
• On examination the following day, the patient had regained full motor functionality, including left
eyebrow raise. Upper and lower extremity sensory, motor and deep tendon reflexes were all intact.
• MRI brain (See figure 1.) showed no evidence of acute infarct or hemorrhage however an incidental
nonspecific punctate hyperintensity on T2 weighted imaging in the left frontal lobe was noted
• Neurology evaluated the patient and determined that the patient may have a stress-related component,
however epinephrine induced vasospasm could not be ruled out. The patient was discharged home on
the day after admission.
This case presents a very rare and previously undocumented reaction from the use of an EpiPen.
Transient global paralysis has never been previously reported as an adverse reaction . The patient
was exposed to a bee sting venom at a young age and was hospitalized due to anaphylactic shock.
After this incident she underwent several years of desensitization with an allergist. It is uncertain
whether desensitization therapy is able to be maintained without further exposure in the following
28 years of life, or even if the patients immune system developed a new and heighted response to
bee venom related antigenic compounds. Bee venom is made up of several toxins and compounds
that cause a proinflammatory response. Studies have shown that it can cause a systemic (including
possible anaphylactic) or localized response [2].
The patient’s presentation is thought to be the first case of global (cerebral and coronary)
vasospasm secondary to epinephrine administration. Epinephrine is known to be dose-dependent
whereby at lower concentrations, beta-related effects are greater, and at higher concentrations
alpha-effects play a greater role. There have been multiple accounts of digital ischemia due to
accidental EpiPen injection. This is secondary to localization of high concentration of epinephrine,
resulting in vascular constriction from α-1 adrenergic stimulation.
It is uncertain whether certain vasculature beds may be more sensitive to adrenergic receptor
stimulation than others. This case presentation suggests is that there was evidence of
hypoperfusion to certain areas following epinephrine administration, as far as 12 hours following
administration. Relating this to the clinical scenario, it leads us to believe that some individuals
are more sensitive to epinephrine stimulation than others. Furthermore, genetics and
environmental factors may play a role in sensitivity toward epinephrine and vasospasm.
Based on the history, physical exam and diagnostic studies, the primary care team built a plan of
treatment to rule out a concerning diagnosis such as a stroke. After analysis of the results,
neurology and the primary team were confident that the patient could be discharged home safely.
The patient was recommended to follow-up with her primary care physician within a week of
discharge. The history of anaphylaxis in response to bee venom is still concerning. The patient
was recommended to continue using her EpiPen in any future incidents as the benefits of the
epinephrine outweigh the risks of possible drug induced vasospasm or temporary neurologic
deficits.
Introduction
Tables and Figures
The EpiPen® is a low dose epinephrine self-administered auto-injection that has been
commercially available since the 1970’s. It is frequently used for relief of allergic reactions in
preventing progression of anaphylactic type reactions. As a sympathomimetic, epinephrine
acts primarily by stimulating a specific few key receptor targets. Stimulation of the α-1
receptors result in vasoconstriction and increased peripheral vascular resistance, while
stimulation the β-2 receptors result in bronchodilation. It additionally functions to decrease
the release of chemotactic mediators from basophils and mast cells. As such, epinephrine
directly counteracts anaphylactic reactions by promoting organ perfusion and airway
protection.
Despite the global distribution and rise in use of epinephrine over the past few decades, not all
patients achieve symptomatic relief from the medication. Individual patient response to
epinephrine may vary based on genetic predispositions and environmental factors.
Furthermore, due to the proposed and understood mechanism of action, a number of side
effects have been reported. Some of the more commonly documented adverse effects include
palpitations and elevated blood pressure levels. More concerning and rare side effects include
fatal ventricular arrhythmias, including ventricular fibrillation, as well as life threatening
hemorrhage such as subarachnoid hemorrhage and hemiplegia [1].
One such rare complication, Kounis syndrome, is a unique presentation of an epinephrine
induced vasospasm that has been documented only a limited number of times [3]. In this
syndrome, the coronary vessels are hypersensitive to epinephrine resulting in symptoms of
angina and rarely can cause myocardial infarction [2]. Ultimately, reporting possible rare
adverse effects of medications, irrespective of how common or how frequently it is used,
should be strongly encouraged in order to promote patient safety and wellness, as well as
physician awareness.
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Table 1. Blood work values through hospital course. Notable findings include initial
presentation with hypokalemia, as well as lactic acidosis 12 hours following admission
despite receiving over 2L of normal saline infusion.
Conclusion
Despite potentially rare and unusual side effects, patients should be encouraged to continue to
use epinephrine in potentially life threatening allergic or anaphylactic reaction settings.
Further research should be undertaken to determine whether certain genetic predisposing
factors may precipitate epinephrine related side effects. This may additionally include further
evaluation of α-1 receptor stimulation testing to determine whether certain environmental
triggers play a role in receptor sensitivity. Given the necessity of maintaining a patent airway
and circulation, rare side effects from epinephrine should not discourage providers from both
educating and prescribing potentially life-saving therapy to patients. Patients should
additionally be instructed on how to monitor for concerning signs when being prescribed the
medication so as to minimize poor outcomes.
